233 related articles for article (PubMed ID: 30804932)
1. New Insights for RANKL as a Proinflammatory Modulator in Modeled Inflammatory Arthritis.
Papadaki M; Rinotas V; Violitzi F; Thireou T; Panayotou G; Samiotaki M; Douni E
Front Immunol; 2019; 10():97. PubMed ID: 30804932
[TBL] [Abstract][Full Text] [Related]
2. RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.
Li P; Schwarz EM; O'Keefe RJ; Ma L; Boyce BF; Xing L
J Bone Miner Res; 2004 Feb; 19(2):207-13. PubMed ID: 14969390
[TBL] [Abstract][Full Text] [Related]
3. A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF.
Douni E; Rinotas V; Makrinou E; Zwerina J; Penninger JM; Eliopoulos E; Schett G; Kollias G
Hum Mol Genet; 2012 Feb; 21(4):784-98. PubMed ID: 22068587
[TBL] [Abstract][Full Text] [Related]
4. RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis.
O'Brien W; Fissel BM; Maeda Y; Yan J; Ge X; Gravallese EM; Aliprantis AO; Charles JF
Arthritis Rheumatol; 2016 Dec; 68(12):2889-2900. PubMed ID: 27563728
[TBL] [Abstract][Full Text] [Related]
5. Bub1 suppresses inflammatory arthritis-associated bone loss in mice through inhibition of TNFα-mediated osteoclastogenesis.
Yoshida S; Ikedo A; Yanagihara Y; Sakaue T; Saeki N; Imai Y
J Bone Miner Res; 2024 Apr; 39(3):341-356. PubMed ID: 38477771
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis.
Polzer K; Neubert K; Meister S; Frey B; Baum W; Distler JH; Gückel E; Schett G; Voll RE; Zwerina J
Arthritis Rheum; 2011 Mar; 63(3):670-80. PubMed ID: 21360496
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor-driven model of rheumatoid arthritis.
Binder NB; Puchner A; Niederreiter B; Hayer S; Leiss H; Blüml S; Kreindl R; Smolen JS; Redlich K
Arthritis Rheum; 2013 Mar; 65(3):608-17. PubMed ID: 23280418
[TBL] [Abstract][Full Text] [Related]
8. Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions.
El Kholy K; Freire M; Chen T; Van Dyke TE
Front Immunol; 2018; 9():1300. PubMed ID: 29946319
[TBL] [Abstract][Full Text] [Related]
9. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
11. Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-κB pathways.
Li CH; Xu LL; Jian LL; Yu RH; Zhao JX; Sun L; Du GH; Liu XY
Int Immunopharmacol; 2018 May; 58():136-144. PubMed ID: 29587202
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic Restriction of TNF-Mediated Inflammatory Osteoclastogenesis and Bone Resorption.
Zhao B
Front Endocrinol (Lausanne); 2020; 11():583561. PubMed ID: 33133025
[TBL] [Abstract][Full Text] [Related]
13. Intravenous Immunoglobulin (IVIG) Attenuates TNF-Induced Pathologic Bone Resorption and Suppresses Osteoclastogenesis by Inducing A20 Expression.
Lee MJ; Lim E; Mun S; Bae S; Murata K; Ivashkiv LB; Park-Min KH
J Cell Physiol; 2016 Feb; 231(2):449-458. PubMed ID: 26189496
[TBL] [Abstract][Full Text] [Related]
14. Novel genetic models of osteoporosis by overexpression of human RANKL in transgenic mice.
Rinotas V; Niti A; Dacquin R; Bonnet N; Stolina M; Han CY; Kostenuik P; Jurdic P; Ferrari S; Douni E
J Bone Miner Res; 2014; 29(5):1158-69. PubMed ID: 24127173
[TBL] [Abstract][Full Text] [Related]
15. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T
Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918
[TBL] [Abstract][Full Text] [Related]
16. Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis.
Ledesma-Colunga MG; Adán N; Ortiz G; Solís-Gutiérrez M; López-Barrera F; Martínez de la Escalera G; Clapp C
Arthritis Res Ther; 2017 May; 19(1):93. PubMed ID: 28506283
[TBL] [Abstract][Full Text] [Related]
17. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
Romas E; Gillespie MT; Martin TJ
Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
[TBL] [Abstract][Full Text] [Related]
18. A monoclonal antibody ameliorates local inflammation and osteoporosis by targeting TNF-α and RANKL.
Qian H; Yuan H; Wang J; Du Y; Zhang X; Sun Y; Li Z; Zhao W
Int Immunopharmacol; 2014 Jun; 20(2):370-6. PubMed ID: 24726242
[TBL] [Abstract][Full Text] [Related]
19. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
20. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
Song J; Jing Z; Hu W; Yu J; Cui X
Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
